JP2024512497A5 - - Google Patents

Info

Publication number
JP2024512497A5
JP2024512497A5 JP2023557369A JP2023557369A JP2024512497A5 JP 2024512497 A5 JP2024512497 A5 JP 2024512497A5 JP 2023557369 A JP2023557369 A JP 2023557369A JP 2023557369 A JP2023557369 A JP 2023557369A JP 2024512497 A5 JP2024512497 A5 JP 2024512497A5
Authority
JP
Japan
Prior art keywords
compound
independently selected
compound according
sulfur
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557369A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024512497A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/020491 external-priority patent/WO2022197763A1/en
Publication of JP2024512497A publication Critical patent/JP2024512497A/ja
Publication of JP2024512497A5 publication Critical patent/JP2024512497A5/ja
Pending legal-status Critical Current

Links

JP2023557369A 2021-03-17 2022-03-16 血漿カリクレインの阻害剤 Pending JP2024512497A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163162487P 2021-03-17 2021-03-17
US63/162,487 2021-03-17
PCT/US2022/020491 WO2022197763A1 (en) 2021-03-17 2022-03-16 Inhibitors of plasma kallikrein

Publications (2)

Publication Number Publication Date
JP2024512497A JP2024512497A (ja) 2024-03-19
JP2024512497A5 true JP2024512497A5 (cg-RX-API-DMAC10.html) 2025-03-24

Family

ID=81326196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023557369A Pending JP2024512497A (ja) 2021-03-17 2022-03-16 血漿カリクレインの阻害剤

Country Status (5)

Country Link
US (1) US20240226106A1 (cg-RX-API-DMAC10.html)
EP (1) EP4308229A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024512497A (cg-RX-API-DMAC10.html)
CN (1) CN117396469A (cg-RX-API-DMAC10.html)
WO (1) WO2022197763A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112135825A (zh) 2018-03-13 2020-12-25 夏尔人类遗传性治疗公司 血浆激肽释放酶抑制剂及其用途
CN114728962B (zh) 2019-09-18 2025-09-19 武田药品工业有限公司 血浆激肽释放酶抑制剂及其用途
WO2021055589A1 (en) 2019-09-18 2021-03-25 Shire Human Genetic Therapies, Inc. Heteroaryl plasma kallikrein inhibitors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DK0495421T3 (da) 1991-01-15 1996-12-09 Alcon Lab Inc Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
KR20020088406A (ko) * 1999-09-17 2002-11-27 애보트 게엠베하 운트 콤파니 카게 치료제로서의 피라졸로피리미딘
AU3950802A (en) * 2000-12-07 2002-06-18 Cv Therapeutics Inc Abca-1 elevating compounds
TW201103904A (en) * 2009-06-11 2011-02-01 Hoffmann La Roche Janus kinase inhibitor compounds and methods
WO2014074715A1 (en) * 2012-11-07 2014-05-15 Genentech, Inc. Cyclopropyl amide derivatives
JP2017500287A (ja) * 2013-11-06 2017-01-05 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Gsk−3阻害剤として有用な置換ピリジン誘導体
WO2015164308A1 (en) * 2014-04-22 2015-10-29 Merck Sharp & Dohme Corp. FACTOR XIa INHIBITORS
EP3578541B1 (en) * 2015-04-17 2025-05-28 Corteva Agriscience LLC Compositions comprising molecules having pesticidal utility, and processes related thereto
CN107849026B (zh) * 2015-07-29 2021-01-01 百时美施贵宝公司 携带烷基或环烷基p2′部分的因子xia大环抑制剂
MX2019010302A (es) * 2017-03-30 2019-11-21 Hoffmann La Roche Isoquinolinas como inhibidores de hpk1.
CN110678466B (zh) * 2017-03-30 2023-01-31 豪夫迈·罗氏有限公司 作为hpk1抑制剂的二氮杂萘类
MY202167A (en) * 2017-11-21 2024-04-12 Bristol Myers Squibb Co Sulfone pyridine alkyl amide-substituted heteroaryl compounds
CN112135825A (zh) 2018-03-13 2020-12-25 夏尔人类遗传性治疗公司 血浆激肽释放酶抑制剂及其用途
WO2021004535A1 (en) * 2019-07-11 2021-01-14 Nanjing Zhengxiang Pharmaceuticals Co., Ltd. Cinnolines as inhibitors of hpk 1
CN114605401B (zh) * 2020-04-28 2023-08-22 江南大学 一类含氧五元杂环化合物、合成方法、药物组合物及用途

Similar Documents

Publication Publication Date Title
JP2024516073A5 (cg-RX-API-DMAC10.html)
JP2024510503A5 (cg-RX-API-DMAC10.html)
JP2022548696A5 (cg-RX-API-DMAC10.html)
JP2024510504A5 (cg-RX-API-DMAC10.html)
JP2019013227A5 (cg-RX-API-DMAC10.html)
JP2023538844A (ja) 補体因子b阻害剤及びその医薬組成物、製造方法並びに用途
JP2022141692A5 (cg-RX-API-DMAC10.html)
WO2000004026A1 (en) Trioxane derivatives
JP2018536634A5 (cg-RX-API-DMAC10.html)
JP2024510502A5 (cg-RX-API-DMAC10.html)
WO2017001307A1 (en) Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
WO2015151490A1 (ja) 新規な三環性キノン誘導体
JP2016513112A5 (cg-RX-API-DMAC10.html)
TW200936581A (en) Fused aminodihydrothiazine derivatives
JP2015516389A5 (cg-RX-API-DMAC10.html)
WO2018111315A1 (en) PYRIMIDINE TRICYCLIC ENONE DERIVATIVES FOR INHIBITION OF RORγ AND OTHER USES
AR045507A1 (es) Derivados de pirrolo [3,2-d] pirimidina
EA020885B1 (ru) Ингибиторы протеинкиназы и их применение
TW200815456A (en) Artemisinin derivative dimers, their preparation and their therapeutic application
JP2022174180A (ja) 化合物、組成物および方法
JP2010514733A5 (cg-RX-API-DMAC10.html)
JP2014527508A5 (cg-RX-API-DMAC10.html)
CN1125048C (zh) 生产异脲的方法
JPS59204189A (ja) ジヒドロピリジル環状イミデ−トエステル
JP2024522201A5 (cg-RX-API-DMAC10.html)